22nd Apr 2025 Benralizumab for the treatment of chronic spontaneous urticaria: a plain language summary of the ARROYO study
21st Feb 2025 Plain language summary of the XALOC-1 program: Real-world study on benralizumab for severe eosinophilic asthma across different biologic treatments and clinical subgroups
22nd Jan 2025 Plain language summary of the SHAMAL study on benralizumab treatment for severe eosinophilic asthma
23rd Sep 2024 Benralizumab treatment outcomes in patients with severe eosinophilic asthma: plain language summary of the ANANKE study
29th May 2024 A plain language summary of the HILLIER study: Treating moderate-to-severe atopic dermatitis with benralizumab
